title: Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
authors: Institute of Neuropathology and Department of Neurology, University Medical Centre, Göttingen, Germany.
authors: Martin S
authors: MS
authors: Weber